The first Analytica Lab Africa took place this July at the Gallagher Convention Center in Johannesburg with 148 exhibitors from 15 countries presenting their products and solutions for the African market.
The first Analytica Lab Africa took place this July at the Gallagher Convention Center in Johannesburg with 148 exhibitors from 15 countries presenting their products and solutions for the African market.
“The past three days have shown that there is a high market demand for the technology and know-how we bring together at Analytica Lab Africa. Exhibitor and visitor expectations were exceeded. The exhibitors noted the high quality of visitors to their stands, especially from market end-users,” said Reinhard Pfeiffer, Deputy CEO of Messe München.
Analytica Lab Africa emerged from Lab Africa following their acquisition in 2017 by Messe München, known for their biannual Analytica trade fair. The acquisition of Lab Africa allowed the company to expand their regional trade fairs to include at least one on the Africa continent.
“Analytica Lab Africa is reaching European standards of excellence. We have seen more customers than expected and the quality of visitors has been very good,” said Nikolai von Knauer, General Manager of Sartorius, South Africa.
Following the success of the event, Messe München plan to continue the series with the next event to be held from
13–15 July 2021, at the Gallagher Convention Centre in Johannesburg.
For more information, please visit: www.analytica-africa.com, www.fdt-africa.com, and www.ifat-africa.com
New Study Uses MSPE with GC–MS to Analyze PFCAs in Water
January 20th 2025Scientists from the China University of Sciences combined magnetic solid-phase extraction (MSPE) with gas chromatography–mass spectrometry (GC–MS) to analyze perfluoro carboxylic acids (PFCAs) in different water environments.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ion used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
A Guide To Finding the Ideal Syringe and Needle
January 20th 2025Hamilton has produced a series of reference guides to assist science professionals in finding the best-suited products and configurations for their applications. The Syringe and Needle Reference Guide provides detailed information on Hamilton Company’s full portfolio of syringes and needles. Everything from cleaning and preventative maintenance to individual part numbers are available for review. It also includes selection charts to help you choose between syringe terminations like cemented needles and luer tips.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Oasis or Sand Dune? Isolation of Psychedelic Compounds
January 20th 2025Magic mushrooms, once taboo, have recently experienced a renaissance. This new awakening is partially due to new findings that indicate the effects of psilocybin, and its dephosphorylated cousin psilocin may produce long lasting results for patients who might be struggling with anxiety, depression, alcohol and drug abuse, and post-traumatic stress disorder. Hamilton Company has developed a methodology for the isolation and identification of 5 common psychedelic compounds used in the potential treatment of disease. The PRP-1 HPLC column resin remains stable in the harsh alkaline conditions ideal for better separations.